
CRL
Charles River Laboratories International Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
177.570
Open
177.145
VWAP
176.22
Vol
740.43K
Mkt Cap
8.69B
Low
173.380
Amount
130.48M
EV/EBITDA(TTM)
12.21
Total Shares
49.12M
EV
11.03B
EV/OCF(TTM)
14.21
P/S(TTM)
2.26
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
983.76M
-4.13%
2.486
-11.2%
959.96M
-4.93%
2.378
-8.19%
964.07M
-3.84%
2.429
-8.67%
Estimates Revision
The market is revising Upward the revenue expectations for Charles River Laboratories International, Inc. (CRL) for FY2025, with the revenue forecasts being adjusted by 1.92% over the past three months. During the same period, the stock price has changed by 53.75%.
Revenue Estimates for FY2025
Revise Upward

+1.92%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+3.35%
In Past 3 Month
Stock Price
Go Up

+53.75%
In Past 3 Month
13 Analyst Rating

-11.50% Downside
Wall Street analysts forecast CRL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRL is 156.58 USD with a low forecast of 100.00 USD and a high forecast of 182.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
9 Hold
0 Sell
Moderate Buy

-11.50% Downside
Current: 176.930

Low
100.00
Averages
156.58
High
182.00

-11.50% Downside
Current: 176.930

Low
100.00
Averages
156.58
High
182.00
Citi
Patrick Donnelly
Neutral -> Buy
upgrade
$150 -> $200
2025-07-09
Reason
Citi
Patrick Donnelly
Price Target
$150 -> $200
2025-07-09
upgrade
Neutral -> Buy
Reason
Citi analyst Patrick Donnelly upgraded Charles River to Buy from Neutral with a price target of $200, up from $150. The firm sees conservatism in the company's second half of 2025 outlook and is comfortable with current 2026 estimates. The activist in Charles River and the company's strategic review process should put a floor valuation in the shares, the analyst tells investors in a research note.
Redburn Atlantic
Neutral -> Buy
upgrade
$188 -> $182
2025-05-23
Reason
Redburn Atlantic
Price Target
$188 -> $182
2025-05-23
upgrade
Neutral -> Buy
Reason
TD Cowen
Hold
to
Buy
upgrade
$179
2025-05-14
Reason
TD Cowen
Price Target
$179
2025-05-14
upgrade
Hold
to
Buy
Reason
TD Cowen upgraded Charles River to Buy from Hold with a $179 price target.
TD Cowen
Hold
to
Buy
upgrade
$105 -> $179
2025-05-14
Reason
TD Cowen
Price Target
$105 -> $179
2025-05-14
upgrade
Hold
to
Buy
Reason
Barclays
Equal Weight
maintain
$145 -> $155
2025-05-08
Reason
Barclays
Price Target
$145 -> $155
2025-05-08
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Charles River to $155 from $145 and keeps an Equal Weight rating on the shares post the Q1 report. The company reported a core beat across the board and raised its outlook by slightly more than the Q1 beat, the analyst tells investors in a research note.
Baird
Neutral
maintain
$118 -> $140
2025-05-08
Reason
Baird
Price Target
$118 -> $140
2025-05-08
maintain
Neutral
Reason
Baird raised the firm's price target on Charles River to $140 from $118 and keeps a Neutral rating on the shares. The firm updated its model following Q1 results where they see green shoots emerging and so raise estimates.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Charles River Laboratories International Inc (CRL.N) is 17.10, compared to its 5-year average forward P/E of 23.29. For a more detailed relative valuation and DCF analysis to assess Charles River Laboratories International Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
23.29
Current PE
17.10
Overvalued PE
29.81
Undervalued PE
16.78
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued
5Y Average EV/EBITDA
15.56
Current EV/EBITDA
11.34
Overvalued EV/EBITDA
19.47
Undervalued EV/EBITDA
11.65
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued
5Y Average PS
3.20
Current PS
2.05
Overvalued PS
4.22
Undervalued PS
2.17
Financials
Annual
Quarterly
FY2025Q1
YoY :
-2.71%
984.17M
Total Revenue
FY2025Q1
YoY :
-31.10%
98.51M
Operating Profit
FY2025Q1
YoY :
-65.26%
25.88M
Net Income after Tax
FY2025Q1
YoY :
-61.54%
0.50
EPS - Diluted
FY2025Q1
YoY :
+121.45%
112.37M
Free Cash Flow
FY2025Q1
YoY :
-11.75%
27.93
Gross Profit Margin - %
FY2025Q1
YoY :
+39.17%
14.00
FCF Margin - %
FY2025Q1
YoY :
-64.27%
2.63
Net Margin - %
FY2025Q1
YoY :
-100.67%
-0.06
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
111.7K
USD
3
3-6
Months
715.0K
USD
1
6-9
Months
1.6M
USD
2
0-12
Months
354.9K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
2
1.3M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
366.4K
Volume
6
6-9
Months
967.3K
Volume
9
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
96.8K
Volume
Months
6-9
4
1.9M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress areBuying! The buying amount has increased100%over the last month.
Sold
0-3
Months
81.0K
USD
4
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
2
65.0K
USD
Months
3-6
1
32.5K
USD
Months
6-9
3
24.0K
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
111.7K
USD
3
3-6
Months
715.0K
USD
1
6-9
Months
1.6M
USD
2
0-12
Months
354.9K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
2
1.3M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CRL News & Events
Events Timeline
2025-07-24 (ET)
2025-07-24
09:55:01
Early notable gainers among liquid option names on July 24th

2025-07-22 (ET)
2025-07-22
09:55:02
Early notable gainers among liquid option names on July 22nd

2025-06-04 (ET)
2025-06-04
09:55:01
Early notable gainers among liquid option names on June 4th

Sign Up For More Events
Sign Up For More Events
News
8.0
07-24NASDAQ.COMNoteworthy Thursday Option Activity: URI, INTC, CRL
9.5
07-24BenzingaRPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday
2.0
07-22BenzingaD.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
Sign Up For More News
People Also Watch

PAC
Grupo Aeroportuario del Pacifico SAB de CV
223.930
USD
+0.46%

FLS
Flowserve Corp
54.840
USD
+0.88%

HLNE
Hamilton Lane Inc
156.860
USD
+0.19%

FSV
FirstService Corp
200.080
USD
+3.13%

KT
KT Corp
20.650
USD
-1.43%

CHE
Chemed Corp
470.720
USD
+1.66%

RH
RH
213.800
USD
+0.50%

MKTX
Marketaxess Holdings Inc
211.450
USD
-1.07%

SARO
StandardAero, Inc.
28.250
USD
-0.35%

LTM
LATAM Airlines Group SA
41.950
USD
+0.60%
FAQ

What is Charles River Laboratories International Inc (CRL) stock price today?
The current price of CRL is 176.93 USD — it has decreased -0.1 % in the last trading day.

What is Charles River Laboratories International Inc (CRL)'s business?

What is the price predicton of CRL Stock?

What is Charles River Laboratories International Inc (CRL)'s revenue for the last quarter?

What is Charles River Laboratories International Inc (CRL)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Charles River Laboratories International Inc (CRL)'s fundamentals?

How many employees does Charles River Laboratories International Inc (CRL). have?
